Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

QTTB

Q32 Bio (QTTB)

Q32 Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:QTTB
일자시간출처헤드라인심볼기업
2024/12/1121:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
2024/12/1121:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
2024/12/1106:05PR Newswire (US)Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development ProgramNASDAQ:QTTBQ32 Bio Inc
2024/11/0721:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
2024/11/0721:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
2024/11/0721:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
2024/11/0720:59PR Newswire (US)Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:QTTBQ32 Bio Inc
2024/11/0520:59PR Newswire (US)Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation ConferenceNASDAQ:QTTBQ32 Bio Inc
2024/10/1709:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
2024/10/1419:59PR Newswire (US)Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024NASDAQ:QTTBQ32 Bio Inc
2024/10/1105:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
2024/09/2810:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
2024/09/2810:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
2024/09/2810:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
2024/09/2810:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
2024/08/2919:59PR Newswire (US)Q32 Bio to Participate in Upcoming September Investor ConferencesNASDAQ:QTTBQ32 Bio Inc
2024/08/1505:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
2024/08/0820:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
2024/08/0820:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
2024/08/0820:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
2024/07/0920:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
2024/07/0920:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
2024/07/0919:59PR Newswire (US)Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic DermatitisNASDAQ:QTTBQ32 Bio Inc
2024/07/0119:59PR Newswire (US)Q32 Bio Joins Russell 3000® IndexNASDAQ:QTTBQ32 Bio Inc
2024/06/0105:25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QTTBQ32 Bio Inc
2024/05/0920:26Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
2024/05/0920:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
2024/05/0920:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
2024/05/0919:59PR Newswire (US)Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:QTTBQ32 Bio Inc
2024/04/0320:00PR Newswire (US)Q32 Bio Appoints Lee Kalowski as President & Chief Financial OfficerNASDAQ:QTTBQ32 Bio Inc
 검색 관련기사 보기:NASDAQ:QTTB